FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 2240091 · Received September 9, 2011

Report

Report Number
6000001-2011-23429
Event Type
Malfunction
Date Received
September 9, 2011
Date of Event
August 15, 2011
Report Date
August 15, 2011
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE FOR EVALUATION. THE REPORTED CONDITION OF A LEAK WAS CONFIRMED. VISUAL EXAMINATION OF THE SAMPLE SHOWED NO SIGNS OF PHYSICAL ABNORMALITY. A FUNCTIONAL LEAK TEST NOTED A LEAK WITHIN THE HOUSING, SPECIFICALLY AT THE WELD AREA OF THE VOLUME INDICATOR PORT. THE ROOT CAUSE WAS DETERMINED TO BE A MANUFACTURING DEFECT: AN IMPROPER SITTING OF THE DUCK BILL VALVE ALLOWED THE SOLUTION TO GO THROUGH THE GAP OBSERVED BETWEEN THE VOLUME INDICATOR AND THE PORT. NO REPAIR WAS DONE, AS THIS IS A SINGLE-USE DEVICE WHICH WILL BE DISCARDED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT.

Additional Manufacturer Narrative · 1

(B)(4). THIS DEVICE IS MANUFACTURED FOR DISTRIBUTION OUTSIDE OF THE UNITED STATES AND DOES NOT HAVE A 510(K) NUMBER. HOWEVER, THIS PRODUCT IS BEING REPORTED BECAUSE IT IS SAME AS OR SIMILAR TO A PRODUCT DISTRIBUTED WITHIN THE U.S. THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WAS MET TO RELEASE THE LOT. THERE WERE NO NONCONFORMITIES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THE DEVICE IS AVAILABLE FOR EVALUATION PER THE CUSTOMER; HOWEVER, THE DEVICE HAS NOT YET BEEN RECEIVED BY BAXTER. SHOULD THE DEVICE BE RECEIVED BY BAXTER FOR EVALUATION, A FOLLOW-UP REPORT WILL BE FILED UPON COMPLETION OF AN EVALUATION OR IF ANY ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

BAXTER (B)(4) RECEIVED A REPORT THAT AN INFUSOR LEAKED ON THE RESERVOIR AND INSIDE THE HOUSING AFTER FILLING. THE DEVICE WAS FILLED WITH A SOLUTION OF ROPIVACAINE, DROPERIDOL, AND MORPHINE. THIS CONDITION HAS THE POTENTIAL TO INTERRUPT THERAPY OR BREACH THE STERILE FLUID PATHWAY. THERE WAS NO PATIENT INVOLVEMENT; THEREFORE, NO PATIENT INJURY, MEDICAL INTERVENTION, OR ADVERSE REACTION IS ASSOCIATED WITH THE REPORTED CONDITION. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 11F013

Patients

Seq Age Sex Outcome Treatment
1